Intrahepatic cholestasis of pregnancy (ICP) is the most common pregnancy-related liver disease. G-protein-coupled bile acid receptor 1 (TGR5) agonists might be beneficial in ICP treatment. This evidence concerns the gene GPBAR1 and Intrahepatic cholestasis of pregnancy.